Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

CVS Caremark Boosts Dividend 22%, Sets $6 Billion Buyback

Dec. 18 (Bloomberg) -- CVS Caremark Corp., the largest provider of prescription drugs in the U.S., boosted its dividend by 22 percent and approved a share buyback for as much as $6 billion.

The quarterly dividend of 28 cents a share is payable Feb. 3 to holders of record on Jan. 23, the Woonsocket, Rhode Island-based said in a statement. The share repurchase is effective immediately and will be completed over a period of several years.

Adjusted profit will be $4.36 to $4.50 in 2014, the company said. Analysts had projected $4.47, on average.

CVS rose 4.3 percent to $69.69 at the close in New York. The shares have added 44 percent this year, compared with a 27 percent gain for the Standard & Poor’s 500 Index.

To contact the reporter on this story: Niamh Ring in New York at nring@bloomberg.net

To contact the editor responsible for this story: Cecile Daurat at cdaurat@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.